Skip to content

Revolution Medicines

US · RVMD #499 by market cap Listed 2020
161.20 +1.77 +1.11%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

StockVane factor grade
C+
Momentum strategy signal
Sell
Analyst consensus
Buy

Signals diverge - worth digging into why.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 23 analysts

Buy
Avg price target 268.26 +66.4%
Price target rangecurrent 161.20
Low179.00
Avg268.26
High350.00
Buy 96% Hold 4% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-20 Bernstein -- Hold 179.00
2026-11-20 Stifel -- Buy 230.00
2026-11-17 H.C. Wainwright -- Buy 350.00
2026-11-13 Morgan Stanley -- Buy 247.00
2026-11-12 BofA Securities -- Buy 274.00
2026-11-09 Stifel -- Buy 230.00
2026-11-09 J.P. Morgan -- Buy 289.00
2026-11-06 Morgan Stanley -- Buy 272.00
2026-11-06 H.C. Wainwright -- Buy 350.00
2026-11-05 TD Cowen -- Buy 270.00
2026-11-05 Piper Sandler -- Buy 222.00
2026-11-05 BofA Securities -- Buy 274.00
2026-11-05 Wedbush -- Buy 225.00
2026-11-05 Morgan Stanley -- Buy 272.00
2026-11-05 Evercore -- Buy 340.00
2026-11-05 Stifel -- Buy 230.00
2026-11-05 Oppenheimer -- Buy 260.00
2026-11-05 RBC Capital -- Buy 321.00
2026-11-04 Guggenheim -- Buy 298.00
2026-11-04 J.P. Morgan -- Buy --
2026-10-27 RBC Capital -- Buy 260.00
2026-10-26 BofA Securities -- Buy 264.00
2026-10-22 UBS -- Buy 265.00
2026-10-22 Morgan Stanley -- Buy 255.00
2026-10-21 TD Cowen -- Buy 250.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-04 After close ±9.93% -11.04% (beat)
2026/Q2 2026-08-05 After close ±8.35% +0.26% (in line)
2026/Q1 2026-05-06 After close ±5.47% -5.67% (beat)
2025/Q4 2026-02-25 After close ±11.64% -1.06% (in line)
2025/Q3 2025-11-05 After close ±8.59% +3.44% (in line)
2025/Q2 2025-08-06 After close ±11.09% -4.69% (in line)
2025/Q1 2025-05-07 After close ±12.35% +11.29% (in line)
2024/Q4 2025-02-26 After close ±8.64% -3.51% (in line)
2024/Q3 2024-11-06 After close ±11.89% -0.54% (in line)
2024/Q2 2024-08-07 After close ±13.30% -0.69% (in line)
2024/Q1 2024-05-08 After close ±17.23% -2.24% (in line)
2023/Q4 2024-02-26 After close ±12.91% +0.79% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:02:24 · For reference only, not investment advice and not tailored to your situation.

Revolution Medicines discussion 0 comments

Add a comment